Immunogen Inc (NASDAQ:IMGN) - Share price - Overview

Stock Report

Immunogen Inc IMGN

Last Price
$9.97

Day Change
-0.09|-0.89%

As of 19/07/2018
16:46:39 EDT | USD
Minimum 15 Minutes Delay.

Last Close10.06
Day Range9.86 - 10.09
Mkt Cap1.46Bil
52-Wk Range4.80 - 13.41
Yield %-
ISINUS45253H1014
Volume1,559,263
P/E-9.23
P/S10.17
P/CF-116.20

Share Price

Financials
201520162017
More ...
Income Statement
Revenue85.5460.00115.45
Operating Income-54.46-124.99-58.20
Net Income-60.74-144.82-96.01
Basic EPS-0.71-1.67-0.98
Avg. Diluted Shares Outstanding868798
Balance Sheet
Current Assets292.18254.78276.34
Non Current Assets21.6432.3118.34
Total Assets313.82287.09294.68
Current Liabilities35.8161.4455.77
Total Liabilities---
Total Equity35.10-82.30-17.90
Cash Flow
Operating Cash Flow-55.29-124.487.65
Capital Expenditure-7.43-10.38-1.12
Free Cash Flow-62.72-134.856.53

In millions, except "Basic EPS". Currency is USD.

Company Profile

Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

293
Key Stats
More ...
Price/Earning TTM-9.31
Price/Book-40.65
Price/Sales TTM10.26
Rev Growth (3 year avg)20.58
EPS Growth (3 year avg)-
Operating Margin % TTM-50.42
Net Margin % TTM-83.17
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.